Substance Use Comorbidity Care: Evidence-Based Stepped Strategies for Depression

药物使用合并症护理：基于证据的抑郁症阶梯策略

• 批准号: 7663663
• 负责人: CARLOS BLANCO
• 金额: $ 53.66万
• 依托单位: NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-01 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7663663
• 关键词: AIDS prevention; Abstinence; Address; Alcohol or Other Drugs use; Algorithms; Behavior Therapy; Behavioral; Caring; Clinic; Clinical; Cognitive; Comorbidity; Complex; Data; Data Analyses; Development; Disease; Disease remission; Drug usage; Educational workshop; Failure; Focus Groups; Frequencies; Future; Goals; Grant; HIV; Health Status; Human Resources; Individual; Injection of therapeutic agent; Intervention; Intervention Studies; Investigation; Lead; Maintenance; Major Depressive Disorder; Manuals; Manuscripts; Measures; Mediator of activation protein; Mental Health; Mental disorders; Methods; Modality; Modeling; Moods; Motivation; Outcome; Patient Self-Report; Patients; Pharmaceutical Preparations; Preparation; Professional counselor; Research; Risk Behaviors; Severities; Staging; Substance Use Disorder; Substance abuse problem; Symptoms; Techniques; Testing; Texas; Training; Treatment outcome; Writing; addiction; base; cognitive behavior therapy; community based treatment; cost; depression; depressive symptoms; design; effective therapy; evidence base; improved; innovation; methadone maintenance; motivational enhancement therapy; pleasure; programs; psychosocial; therapy development; treatment strategy

Depression is the most common co-occurring psychiatric disorder in individuals with substance use disorders (SUD). Depression has been associated with both severity of addiction and poor treatment outcome. Previous attempts at treating major depressive disorder (MDD) in individuals with SUD have been hampered by at least one of three limitations: 1) Failure to integrate the treatment of MDD and SUD in one intervention, causing untreated mood symptoms to lead to substance use, while the substance use contributed to the maintenance of mood symptoms; 2) Use of single treatment modalities (e.g., medication alone), also leading to small improvement in most patients; and, 3) Use of complex cognitive interventions requiring highly trained personnel that increase the cost of the interventions and limit their future applicability. The goal of the present application is to start to address this problem. The focus of this Stage Ia proposal is the development and initial testing of a stepped-care model to provide integrated treatment for SUD and MDD. The intervention, which we preliminarily call Substance Use Comorbidity Care: Evidence-Based Stepped Strategies for Depression (SUCCESS-D) will overcome prior limitations by: 1) Providing integrated treatment of SUD and MDD; 2) Using behavioral and pharmacological interventions; and, 3) Creating an intervention that is counselor-driven to increase feasibility. The combination of provision of integrated treatment and use of complementary treatment approaches should lead to better mood and substance use outcomes, thus addressing a major unsolved need in the treatment of SUD. The first level of SUCCESS-D, delivered by counselors, will integrate motivational interviewing (MI) and behavioral activation techniques to decrease drug use, promote treatment retention, and reduce depressive symptoms. At the second level, a pharmacological algorithm, the Texas Medication Algorithm for Depression (TMA-D) will be implemented to treat the depressive symptoms of individuals who fail to achieve remission with the first step of SUCCESS-D, while cognitive-behavioral treatment will be offered to those who continue to use substances. It is hoped that this integrated intervention will constitute a more comprehensive and potentially more effective treatment model than currently existing approaches. Data from this study, which will be conducted in a large methadone maintenance clinic and a large drug-free program, will help plan future intervention studies that will use stepped-care models to provide appropriate treatment strategies for substance abuse patients with other co-occurring disorders or in more diverse community-based treatment settings.

抑郁症是物质使用障碍(SUD)患者中最常见的共生精神障碍。抑郁症与成瘾的严重程度和糟糕的治疗结果都有关。先前治疗严重抑郁障碍(MDD)的尝试至少受到以下三个限制之一的阻碍：1)未能将MDD和SUD的治疗整合在一个干预措施中，导致未经治疗的情绪症状导致药物使用，而药物的使用导致情绪症状的维持；2)使用单一的治疗方式(例如单独用药)，也导致大多数患者的病情略有改善；以及3)使用复杂的认知干预措施，需要训练有素的人员，这增加了干预措施的成本，并限制了其未来的适用性。本申请的目标是开始解决这一问题。 这一阶段Ia提案的重点是开发和初步测试阶梯式护理模式，以提供对SUD和MDD的综合治疗。我们初步将这项干预称为物质使用共病护理：基于证据的抑郁症阶段性策略(Success-D)，它将通过以下方式克服先前的限制：1)提供SUD和MDD的综合治疗；2)使用行为和药物干预；以及3)创建一种由辅导员驱动的干预措施，以增加可行性。综合治疗的提供和补充治疗方法的使用相结合，应该会带来更好的情绪和物质使用结果，从而解决SUD治疗中一个尚未解决的主要需求。 由咨询师提供的Success-D的第一个级别将整合动机访谈(MI)和行为激活技术，以减少药物使用，促进治疗保持，并减少抑郁症状。在第二个层面，将实施一种药理学算法-德克萨斯州抑郁症药物算法(TMA-D)，以治疗未能通过Success-D的第一步实现缓解的个人的抑郁症状，而认知行为治疗将提供给那些继续使用药物的人。人们希望，这一综合干预将构成一种比目前的方法更全面、可能更有效的治疗模式。 这项研究的数据将在一个大型美沙酮维持诊所和一个大型无毒项目中进行，将有助于规划未来的干预研究，这些研究将使用分步护理模式，为患有其他共生疾病或在更多样化的社区治疗环境中的药物滥用患者提供适当的治疗策略。